Contact this trialFirst, we need to learn more about you.
AKT Inhibitor
ALTA2618 for Cancer
Recruiting1 awardPhase 1
San Antonio, Texas
This trial aims to understand how safe and well-tolerated ALTA2618 is in adults with a specific type of advanced solid tumors called AKT1 E17K-mutant tumors.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service